Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CERT
Certara, Inc. Common Stock
stock NASDAQ

At Close
Aug 3, 2026 3:59:57 PM EDT
8.17USD+0.864%(+0.07)3,668,381
6.88Bid   8.18Ask   1.30Spread
Pre-market
Aug 3, 2026 9:29:30 AM EDT
8.32USD+2.716%(+0.22)10,020
After-hours
Aug 3, 2026 4:00:30 PM EDT
8.18USD+0.122%(+0.01)942,846
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 11, 2022
10:11AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2022   Benzinga
05:09AM EST  Jefferies Upgrades Certara to Buy, Announces $31 Price Target   Benzinga
Dec 21, 2021
08:02AM EST  Certara Announces FDA Renewal And Expansion Of Certara's Biosimulation Software For Reviewing Regulatory Submissions   Benzinga
08:00AM EST  Certara Announces FDA Renewal and Expansion of   GlobeNewswire Inc
Dec 13, 2021
08:00AM EST  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates the Companys flagship software for preparing clinical trial data for biosimulation and regulatory submission.   GlobeNewswire Inc
Dec 8, 2021
05:00PM EST  Certara to Host Investor Day on December 15, 2021   GlobeNewswire Inc
Dec 2, 2021
08:10AM EST  Certara Announces Release Of Simcyp Simulator Version 21, Expanding Capabilities To Align With Recent Regulatory Guidances   Benzinga
08:00AM EST  Certara Announces Release of   GlobeNewswire Inc
Nov 29, 2021
04:30PM EST  Certara Announces Update of D360 Scientific   GlobeNewswire Inc
Nov 22, 2021
05:45PM EST  Certara Announces Closing of Public Offering of Common Stock   GlobeNewswire Inc
Nov 18, 2021
11:10AM EST  Shares of Certara, Inc. (CERT) slipped over 10% on Thursday morning. CERT is currently trading at $32.16, down $3.85 or 10.69%, on the Nasdaq.   RTTNews
Nov 17, 2021
11:27PM EST  Certara Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
Nov 15, 2021
06:49PM EST  Certara Announces Proposed Public Offering Of 10M Shares Of Common Stock   Benzinga
Nov 9, 2021
06:27PM EST  Certara Raises FY21 Sales Guidance From $283M-$289M To $286M-$289M Vs. $285.71M Est.   Benzinga
06:26PM EST  Certara Q3 EPS $0.07 Beats $0.06 Estimate, Sales $73.94M Beat $72.82M Estimate   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
11:14AM EST  Certara Appoints James E. Cashman III As Chairman Of Board Of Directors   Benzinga
Nov 3, 2021
08:00AM EDT  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference.   GlobeNewswire Inc
Oct 28, 2021
08:00AM EDT  Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services   GlobeNewswire Inc
Oct 25, 2021
04:30PM EDT  Certaras Simcyp COVID-19   GlobeNewswire Inc
Oct 19, 2021
08:00AM EDT  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2021 after the market close on Tuesday, November 9th, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.   GlobeNewswire Inc
Oct 12, 2021
08:00AM EDT  Certara Appoints Patrick F. Smith to President of Integrated Drug   GlobeNewswire Inc
Oct 5, 2021
08:00AM EDT  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position of Chief Commercial Officer. In this role, Mr. Virkler will drive the Companys global commercial strategy and execution and expand the business development team.   GlobeNewswire Inc
Oct 4, 2021
08:00AM EDT  Certara Completes Acquisition of Pinnacle 21   GlobeNewswire Inc
Sep 30, 2021
04:30PM EDT  Certara, a global leader in biosimulation, today announced the launch of Synchrogenix Writer, a new regulatory SaaS product that expedites the authoring and review of patient narratives. Patient narratives describe adverse events or adverse drug reactions and are critical to clinical study reporting across every therapeutic area throughout the clinical phases.   GlobeNewswire Inc
Sep 22, 2021
08:00AM EDT  Certara Announces New Clinical Science Group and Adds Senior   GlobeNewswire Inc
Sep 20, 2021
08:03AM EDT  Certara Awarded FDA Grant To Further Advance Virtual Bioequivalence Assessments Of Generic Medicines Using Biosimulation   Benzinga
08:00AM EDT  Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug Administration (FDA) to verify and expand biosimulation models for assessing virtual bioequivalence (VBE) to help enable safer, faster and more cost-effective generic drug product development.   GlobeNewswire Inc
Sep 13, 2021
04:30PM EDT  Certara Announces Closing of its Public Offering of Common Stock   GlobeNewswire Inc
Sep 9, 2021
05:35AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.25 A.M. EDT).   RTTNews
Sep 8, 2021
09:01PM EDT  Certara Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
Sep 3, 2021
06:11AM EDT  Certara Announces Proposed Public Offering Of 20M Shares Of Common Stock   Benzinga
06:10AM EDT  Certara Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Aug 31, 2021
04:30PM EDT  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the following virtual investor conferences:   GlobeNewswire Inc
Aug 6, 2021
08:11AM EDT  Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 Guidance   Benzinga
07:59AM EDT  UPDATE: Certara Q2 Adj. EPS $0.03   Benzinga
Aug 5, 2021
06:15PM EDT  Certara Q2 EPS $(0.02) Misses $0.05 Estimate, Sales $70.10M Beat $69.40M Estimate   Benzinga
04:16PM EDT  Certara To Buy Pinnacle 21 For $310M In Cash, Stock   Benzinga
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Jul 27, 2021
05:10PM EDT  Certara Enters Agreement Under Which Mubadala Affiliate Will Purchase 9.615M Shares At $26/Share   Benzinga
05:03PM EDT  Certara (NASDAQ: CERT),a global leader in biosimulation, today announced that Mubadala Investment Company (Mubadala) has made an approximately $250 million investment in Certara. The investment aligns with Mubadalas strategy of enabling innovation to address unmet clinical needs and drive cost efficiencies.   GlobeNewswire Inc
Jul 23, 2021
05:30PM EDT  Certaras Vaccine Simulator   GlobeNewswire Inc
10:24AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021   Benzinga
06:33AM EDT  Baird Initiates Coverage On Certara with Outperform Rating, Announces Price Target of $30   Benzinga
Jul 15, 2021
04:33PM EDT  Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors, effective August 1, 2021. The two additional appointments increase the companys board of directors to eleven members.   GlobeNewswire Inc
08:06AM EDT  Argus Research Initiates Equity Report Coverage on Cerrado Gold (TSXV: CERT)   PR Newswire
07:08AM EDT  OTC Markets Group Welcomes Cerrado Gold Inc. to OTCQX   PR Newswire
Jul 14, 2021
04:32PM EDT  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of 2021 after the market close on Thursday, August 5, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.   GlobeNewswire Inc
Jul 13, 2021
08:02AM EDT  Certara, a global leader in biosimulation, today announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources Officer (CHRO). Sherman joins Certara with extensive experience in the biopharmaceutical industry, leading HR strategy and implementing programs to drive business impact.   GlobeNewswire Inc
Jul 8, 2021
08:02AM EDT  Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication software platform to include new capabilities that can provide biopharmaceutical and medical device companies greater commercial success for new therapies and products.   GlobeNewswire Inc
Jun 23, 2021
07:00PM EDT  Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of Certaras Simcyp and Phoenix biosimulation software. The PMDA has been using Certaras biosimulation software since 2014.   GlobeNewswire Inc
Jun 14, 2021
08:00AM EDT  Certara, a global leader in biosimulation, today announced the addition of Carol Gallagher, Pharm.D., to its board of directors. Dr. Gallagher is an experienced biopharmaceutical director and operator and serves as a venture partner at New Enterprise Associates (NEA), a global venture capital firm.   GlobeNewswire Inc
May 20, 2021
08:00AM EDT  Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences:   GlobeNewswire Inc
May 13, 2021
08:04AM EDT  Certara Highlights New Versions Of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators For Expediting Development Of Biologics And Immuno-oncology Therapies   Benzinga
08:00AM EDT  Certara Releases New Versions of Its Preeminent Quantitative   GlobeNewswire Inc
May 7, 2021
05:00PM EDT  Cerrado Gold Virtually Closes The Market   PR Newswire
May 6, 2021
05:42PM EDT  Certara Sees FY21 Sales $277M-$285M Vs. $280.71M Est.   Benzinga
05:41PM EDT  Certara Q1 Sales $66.70M, Adj. EBITDA $23.9M, Net Income $1.1M   Benzinga
05:41PM EDT  Certara Q1 EPS $0.06 Up From $0.02 YoY, Sales $66.70M Up From $57.40M YoY   Benzinga
Apr 30, 2021
08:00AM EDT  Certara to Present at the BofA Securities 2021 Virtual Health Care Conference   Business Wire
Apr 22, 2021
04:15PM EDT  Certara to Report Preliminary First Quarter 2021 Financial Results on May 6, 2021   Business Wire
Mar 29, 2021
03:00PM EDT  Certara Announces Closing of Public Offering of Common Stock   Business Wire
Mar 25, 2021
09:44AM EDT  Shares of Certara Inc. (CERT) are rising over 13% Thursday morning, after the company announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders at a price to the public of $25.00 per share.   RTTNews
Mar 24, 2021
10:17PM EDT  Certara Announces Pricing Of Secondary Offering Of 10 Mln Shares At $25.00/shr   RTTNews
09:44PM EDT  Certara Announces Pricing of Public Offering of Common Stock   Business Wire
Mar 22, 2021
04:55PM EDT  Certara Reports 17M Share Common Stock Offering Via Selling Shareholders   Benzinga
04:53PM EDT  Certara Announces Proposed Public Offering of Common Stock   Business Wire
04:34PM EDT  Certara Files For Common Stock Offering Of 17M Shares   Benzinga
Mar 16, 2021
09:06AM EDT  TrialAssure Reports Certara License Co.'s ANONYMIZE Software To Anonymize Clinical Data   Benzinga
Mar 11, 2021
10:00AM EST  Certara Set to Join Russell 1000(r) Index   Business Wire
Mar 8, 2021
10:52AM EST  Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $33   Benzinga
Mar 4, 2021
04:13PM EST  Certara Q4 EPS $0.09 Beats $0.03 Estimate, Sales $64.64M Beat $60.97M Estimate   Benzinga
04:10PM EST  Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance   Business Wire
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Mar 3, 2021
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021   Benzinga
06:32AM EST  Barclays Initiates Coverage On Certara with Overweight Rating, Announces Price Target of $40   Benzinga
Feb 26, 2021
11:17AM EST  Certara to Present at the Barclays Global Healthcare Conference   Business Wire
Feb 25, 2021
03:19PM EST  The Year 2020 Marks the 7th Consecutive Year Certara Customers Received 90 Percent of US FDA Novel Drug and Biologic Approvals   Business Wire
Jan 6, 2021
10:14AM EST  Benzinga's Top Upgrades, Downgrades For January 6, 2021   Benzinga
09:49AM EST  Morgan Stanley Initiates Coverage On Certara with Equal-Weight Rating, Announces Price Target of $35   Benzinga
Jan 5, 2021
10:11AM EST  Benzinga's Top Upgrades, Downgrades For January 5, 2021   Benzinga
10:05AM EST  William Blair Initiates Coverage On Certara with Outperform Rating   Benzinga
07:34AM EST  Credit Suisse Initiates Coverage On Certara with Neutral Rating, Announces Price Target of $35   Benzinga
07:32AM EST  B of A Securities Initiates Coverage On Certara with Buy Rating, Announces Price Target of $41   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 16, 2020
06:30PM EST  Certara Announces Closing of Its Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares   Business Wire
Dec 11, 2020
11:59AM EST  Certara Shares Halted On Circuit Breaker   Benzinga
11:43AM EST  Certara Shares Open For Trade At $29.90; IPO Priced At $23/Share   Benzinga
10:12AM EST  Certara Shares Indicated $29.90 On ~330K Shares; IPO Priced At $23/Share   Benzinga
09:46AM EST  IPOs for today: VVOS, ABCL, EDTXU, GLAQU, TVACU, SNRHU, NBTX, ROCCU, GHVIU, CERT, FDMT, MOTVU, DWINU, CBAHU, PCPCU   Benzinga
09:14AM EST  Certara Shares Will Open For Quote At 10:10 a.m. EST, Expected To Open For Trade After 10:20 a.m. EST; IPO Priced At $23/Share   Benzinga
08:21AM EST  Benzinga Pro's Top 5 Stocks To Watch For Friday, Dec. 11, 2020: DIS, PTON, CERT, VTVT, GIK   Benzinga
Dec 10, 2020
08:49PM EST  Certara Announces Pricing Of Its Upsized IPO Of 29.06 Mln Shares At $23.00/shr   RTTNews
07:30PM EST  Certara Announces Pricing of Its Upsized Initial Public Offering   Business Wire
Dec 7, 2020
01:52PM EST  Previewing This Week's IPOs   Benzinga
Dec 6, 2020
10:50AM EST  IPO Outlook For The Week: Airbnb, DoorDash Lead Highly Anticipated Week   Benzinga
Dec 3, 2020
08:10AM EST  Certara Says Launches IPO Of 24.39 Mln Shares Pursuant To Registration Statement Filed With The SEC   RTTNews
08:00AM EST  Certara Announces Launch of Initial Public Offering   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC